R&D | April 18, 2026
ANRF CEO calls for excellence-led innovation at SRMIST Research Day
Dr Shivkumar Kalyanaraman emphasizes need for quality research, partnerships, and measurable outcomes
Dr Shivkumar Kalyanaraman emphasizes need for quality research, partnerships, and measurable outcomes
The company stated that it will work closely with the regulator to address the observations within the stipulated timeframe
Collaboration integrates AJICAP™ technology with global manufacturing capabilities to streamline antibody-drug conjugate pipelines
Zero-observation outcomes strengthen global credibility and accelerate CDMO ambitions
TheraNym will set up a greenfield large-scale mammalian drug substance manufacturing facility
Acquires 85% stake in the formulations company valued at Rs 200 crore enterprise value; founder Vivek Seth to retain 15%
Discussions will focus on how private space stations can improve access, repeatability and commercial feasibility for advanced biotech experiments
The collaboration combines Alveus’ expertise in metabolic biology and therapeutic strategy with Aurigene’s integrated discovery capabilities
The CE Mark builds on the company’s ISO 13485 certification, further strengthening confidence in the platform's safety, quality and performance
The event marks a significant push into South Korea’s rapidly expanding bio-health ecosystem
Subscribe To Our Newsletter & Stay Updated
